|
Personalized Medicine, Big Companies to Lead MedTech Growth to 2018
In vitro diagnostics (IVD) could claim the lion’s share of a $440 billion global medtech market in 2018, thanks to the rise of personalized medicine, a new report by London consulting group EvaluateMedTech says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives